Company: IPODW
Filing Date: 2025-03-07
Form Type: S-1
Source: 0001213900-25-021721
Chunk: 127

Company: Dune Acquisition Corp II
Filing Date: 2025-03-07
Form: S-1
Chunk 127
---
 our initial business combination and may negatively affect our reputation, which may impede our ability to complete an initial business combination. Members of our management team and affiliated companies may have been, and may in the future be, involved in civil disputes or governmental investigations unrelated to our business. Members of our management team have been (and intend to be) involved in a wide variety of businesses. Such involvement has, and may lead to, media coverage and public awareness. As a result, members of our management team and affiliated companies may have been, and may in the future be, involved in civil disputes or governmental investigations unrelated to our business. Any such claims or investigations may be detrimental to our reputation and could negatively affect our ability to identify and complete an initial business combination and may have an adverse effect on the price of our securities. Our letter agreement with our sponsor, officers and directors may be amended without shareholder approval. Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities. If the non-managing sponsor investors purchase units in this offering, it could reduce the trading volume, volatility and liquidity for our shares, and adversely affect the trading price of our shares. As of the date of this prospectus, the non -managingsponsor investors have not expressed to us an interest in purchasing the units in this offering. There is no limit on the number of units to be sold in this offering that may be purchased by any of the non -managingsponsor investors, and any units sold in this offering purchased by the non -managingsponsor investors would not be subject to contractual lock -uplimitations. The non -managingsponsor investors may determine to purchase any or no units in this offering or the underwriters may determine